Advances in diagnosis and management of cancer of the esophagus

N Deboever, CM Jones, K Yamashita, JA Ajani… - bmj, 2024 - bmj.com
Esophageal cancer is the seventh most common malignancy worldwide, with over 470 000
new cases diagnosed each year. Two distinct histological subtypes predominate, and …

Risk stratification for synchronous/metachronous recurrence after endoscopic submucosal dissection for Barrett's esophageal adenocarcinoma using the length of …

Y Ikenoyama, K Namikawa, M Takamatsu… - Esophagus, 2024 - Springer
Background In Japan, the standard management of Barrett's esophageal adenocarcinoma
after endoscopic submucosal dissection involves follow-up; however, multifocal …

AGA Clinical Practice Guideline on Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia

JH Rubenstein, T Sawas, S Wani, S Eluri, S Singh… - Gastroenterology, 2024 - Elsevier
Background & Aims Barrett's esophagus (BE) is the precursor to esophageal
adenocarcinoma (EAC). Endoscopic eradication therapy (EET) can be effective in …

[HTML][HTML] Comparing the effects of argon plasma coagulation and interferon therapy in patients with vaginal intraepithelial neoplasia: a single-center retrospective study

Y Gao, W Chu, L Hou, J Cheng, G Zhong, B Xia… - Archives of Gynecology …, 2024 - Springer
Purpose This study aimed to evaluate the clinical efficacy and safety of argon plasma
coagulation (APC) therapy and interferon therapy in patients with grade I and II vaginal …

[PDF][PDF] American Gastroenterological Association Clinical Practice Guideline: Endoscopic Eradication Therapy of Barrett's Esophagus and Related Neoplasia

JH Rubenstein, T Sawas… - …, 2024 - aga-fileuploader-bucket.s3.us-east-2 …
Endoscopic eradication therapy (EET) can be effective in eradicating BE and related
neoplasia, and has greater risk of harms and resource use than surveillance endoscopy …